Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units

Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units

US Patent 10364425 · Granted Jul 30, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of modified Fc fragments in immunotherapy2025
Markers of immune response2021
Sialylated fetuin-A as a marker of immunotherapy efficacy2021
Affinity chromatography matrix2020
Method for preparing universal plasma2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Methods for identifying dendritic cell subsets, for determining if a patient is 2019
Biomarkers of immunotherapy efficacy2018
Monoclonal antibodies with enhanced ADCC function2018
Monoclonal antibodies with enhanced ADCC function2018